Ranozex Tablet ER
Marketer
Sun Pharmaceutical Industries Ltd
Salt Composition
Ranolazine (500mg)
Overview Ranozex Tablet ER
Extended-release Ranozex tablets treat angina pectoris (chest pain stemming from heart issues). This medication proactively reduces angina episodes but won't halt an attack already in progress. It eases chest discomfort by enhancing cardiac efficiency. Follow your physician's prescribed dosage and timing, taking the tablets consistently each day. Ingesting them with food minimizes potential stomach irritation. Your doctor determines the appropriate frequency, potentially adjusting it based on your response. Consistent use, even when feeling well, is crucial for ongoing protection against future angina. Discontinuation may trigger a recurrence of chest pain. Complementing this medication with a healthy lifestyle – including smoking cessation, moderate alcohol consumption, a balanced diet, regular physical activity, and stress management – further supports heart health. While generally well-tolerated, common side effects such as nausea, vomiting, headache, dizziness, constipation, and fatigue may occur. Report any persistent or bothersome side effects to your doctor. Ranozex ER may be unsuitable for certain individuals. Inform your doctor of any liver or kidney conditions, and disclose all other medications you're taking, as interactions are possible. This medication is generally not advised during pregnancy or breastfeeding.
Uses of Ranozex Tablet ER
Managing chest pain associated with angina pectoris
Major Benefits of Ranozex Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the extended-release Ranozex Tablet whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
Common Side effects of Ranozex Tablet ER:
- Nausea
- Vomiting
- Headache
- Dizziness
- Constipation
- Weakness
How to use Ranozex Tablet ER:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; do not crush, chew, or fracture it. Administer Ranozex Extended-Release tablets with a meal.
How Ranozex Tablet ER works:
Ranozex Extended-Release tablets are used to treat angina. Their mechanism of action involves reducing the heart's oxygen demand through myocardial relaxation.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Ranozex Tablet ER and alcohol consumption: The safety of this combination is undetermined. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Extended-release Ranozex tablets might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Physician consultation is advised.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Ranozex tablets are likely not safe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Ranozex Extended-Release Tablets on driving ability is undetermined. Refrain from operating a vehicle if you exhibit any symptoms impairing concentration or reaction time.
KidneyCAUTION
Individuals with kidney impairment should use Ranozex ER tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Ranozex ER tablets are contraindicated for patients exhibiting severe kidney disease.
LiverCAUTION
Patients with liver impairment should exercise caution when using Ranozex ER tablets, as dose modification may be necessary. Consult a physician for guidance. Ranozex ER tablets are contraindicated in individuals with moderate to severe hepatic dysfunction.
What if you forget to take Ranozex Tablet ER :
Should you forget a dose of Ranozex Extended-Release Tablets, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Ranozex Tablet ER
| Label | Value |
|---|---|
| Chemical Category | Piperazine-acetanilide hybrid |
| Developing Habits | No. |
| Treatment Category | Heart |
| Behavior Class | Angina treated with late sodium channel blockers |








